机译:肝肿瘤细胞系HepG2的表观遗传修饰增加了它们的药物代谢能力
Eberhard Karls Univ Tubingen Siegfried Weller Inst BG Trauma Clin D-72076 Tubingen Germany;
Univ Leipzig Dept Hepatobiliary Surg &
Visceral Transplantat D-04103 Leipzig Germany;
Royan Inst Stem Cell Biol &
Technol Dept Stem Cells &
Dev Biol Tehran 16635148 Iran;
Eberhard Karls Univ Tubingen Siegfried Weller Inst BG Trauma Clin D-72076 Tubingen Germany;
Eberhard Karls Univ Tubingen Siegfried Weller Inst BG Trauma Clin D-72076 Tubingen Germany;
Eberhard Karls Univ Tubingen Siegfried Weller Inst BG Trauma Clin D-72076 Tubingen Germany;
Univ Hosp Tubingen Dept Gen Visceral &
Transplant Surg D-72076 Tubingen Germany;
Univ Hosp Tubingen Dept Gen Visceral &
Transplant Surg D-72076 Tubingen Germany;
Univ Leipzig Dept Hepatobiliary Surg &
Visceral Transplantat D-04103 Leipzig Germany;
Eberhard Karls Univ Tubingen Siegfried Weller Inst BG Trauma Clin D-72076 Tubingen Germany;
Eberhard Karls Univ Tubingen Siegfried Weller Inst BG Trauma Clin D-72076 Tubingen Germany;
tumor cells; epigenetic reprogramming; drug metabolism; hepatoma cell lines; primary human hepatocytes;
机译:肝肿瘤细胞系HepG2的表观遗传修饰增加了它们的药物代谢能力
机译:NRF2通过磺化物的表观遗传修饰增加了阿尔茨海默病细胞模型中的抗氧化和抗炎能力
机译:通过在肿瘤三维模型中提高稳定性,药物递送效率和细胞毒性作用,mTHPC加载的细胞外囊泡优于脂质体和游离的mTHPC制剂
机译:核糖核苷酸修饰的综合地图作为细胞身份,表观遗传和代谢状态的可能指标
机译:通过代谢和表观遗传法规靶向肿瘤引发干细胞
机译:肝肿瘤细胞系HepG2的表观遗传修饰增加其药物代谢能力。
机译:肝肿瘤细胞系HepG2的表观遗传修饰增加了它们的药物代谢能力